Gankyrin Activates IL-8 to Promote Hepatic Metastasis of Colorectal Cancer.

Bibliographic Details
Title: Gankyrin Activates IL-8 to Promote Hepatic Metastasis of Colorectal Cancer.
Authors: Zhaofang Bai1, Yanhong Tai2, Weihua Li3, Cheng Zhen1, Weiting Gu3, Zhao Jian1, Qianyi Wang1, Lin, Jieru E.4, Qing Zhao1, Weili Gong1, Bing Liang1, Chenguang Wang3 Chenguang.Wang@jefferson.edu, Tao Zhou1 tzhou@ncba.ac.cn
Source: Cancer Research. Jul2013, Vol. 73 Issue 14, p4548-4558. 11p.
Subject Terms: *LIVER metastasis, *METASTASIS, *COLON cancer, *INTERLEUKIN-1, *GENOMES
Abstract: Hepatic metastasis is responsible for the majority of colorectal cancer (CRC)-related mortalities. Although Gankyrin (PSMD10) has been implicated in cancer metastasis, its exact role and underlying mechanisms of CRC hepatic metastasis remain largely unknown. Herein, we showed that the expression of Gankyrin was higher in primary CRC with hepatic metastasis compared with CRC without metastasis. RNAi-mediated silencing of Gankyrin expression in highly metastatic human CRC cells impaired their migratory and metastatic capacity in vivo. Genome-wide transcriptome profiling revealed activation of the interleukin (IL)-8 signaling pathway by Gankyrin. Protein levels of IL-8 and cyclin D1 (CCND1), the two important molecules in the IL-8 pathway, were positively correlated with Gankyrin expression in human CRC specimens. Furthermore, genetic deletion of cyclin D1 showed its requirement in Gankyrin-mediated cell migration. Finally, administration of recombinant IL-8 rescued the migratory defect of CRC cells where Gankyrin expression was silenced. Together, our findings highlight the importance of Gankyrin in hepatic metastasis of CRC and point out its candidature as a potential prognostic marker and therapeutic target to improve the clinical management of metastatic CRC. [ABSTRACT FROM AUTHOR]
Copyright of Cancer Research is the property of American Association of Cancer Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:00085472
DOI:10.1158/0008-5472.CAN-12-4586
Published in:Cancer Research
Language:English